BioAmber
closedRenewable chemistry company using agricultural crops and transform them into green chemicals that directly substitute chemicals derived from oil.
Launch date
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Feb 2012.)
Plymouth United States (HQ)
Financials
Estimates*
USD | 2017 |
---|---|
Revenues | 14.0m |
EBITDA | (27.0m) |
% EBITDA margin | (193 %) |
Profit | (98.0m) |
% profit margin | (700 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$12.0m | Series A | ||
$45.0m | Series B | ||
$30.0m | Series C | ||
N/A | $80.0m | IPO | |
N/A | $25.0m | Debt | |
N/A | $10.0m | Debt | |
N/A | $7.0m | Grant | |
N/A | $10.0m | Debt | |
Total Funding | CAD128m |
Related Content
Recent News about BioAmber
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.